An expert in cardiovascular physiology and the physiology of the effort, he served as a member of the National Council for Health Promotion in the Ministry of Health, the National Board of Cardiology, as well as many other committees in the field of cardiac rehabilitation and gyms. Member of the Ministry of Health committees on the subject of "Rehabilitation of cardiac patients". Member of the World Health Organization Network for Health Exercise. Associate member of the American College of Sports Medicine (ACSM), Professor Schinowitz runs a research lab studying the physiology of the effort, combining fields from basic research to applied clinical research. Professor Schinowitz is at the head of the Biomedical Technology Innovation Program and head of department of Biomedical Engineering at TAU.
Dr. Khaled Khalil is the founder of Alfa Rhythm and developer of the unique method of frequency therapy. As a specialist in herbal medicine, researcher and therapist, in his clinic Dr. Khaled treated a variety of symptoms and illnesses that seemed to have no appropriate medical solution. Over the years, with the use of practical experience and ancient texts, he has acquired a great amount of knowledge on herbal medicine. In the past few years, he committed his diligence to the development of Alfa Rhythm's device with the help of leading professionals in the field, and so registered a patent on several devices based on the frequency therapy method.
Prof. Levy joined Pharmacid in the year 2010 and serves as a chief scientific officer and thus a liaison to the Pharmacid Scientific Advisory Committee. Prof. Levy was the Head of the Radiochemistry Department in the Nuclear Research Center NEGEV (NRCN) for 13 years (1965-1973). In-between the years 1977 and 2007, he served as a researcher at the Israeli Institute of Biological Research, IIBR, for 13 years as the Head of Department of Pharmacology. Prof. Levi holds a PhD from the Hebrew University of Chemistry, a PhD in Pharmacology at the Roche Institute of Molecular Biology and candidacy as a professor at Ben-Gurion University of the Negev, Beer Sheva. From 1995-200, Prof. Levi served on the board of directors of the Brom Dead Sea Group as the Head of the Research Committee.
Dr. Mohammad Hamdan, a specialist in otolaryngology, neck and head surgery at the French Hospital of Nazareth, works in collaboration with the Rambam Medical Center, Bnei Zion Medical Center and Carmel Medical Center in Haifa and participated in many journals, some of them being: Otoneurology Journal, Transoral robot surgery, Rhinology and Sinonasal Surgery.
Dr. Shirazi PhD, chemist, pharmaceutical researcher and physician of natural medicine. Was globally responsible for research and development of products, quality systems, testing and product safety in the pharmaceutical and nutritional industry in Canada and the USA. Dr. Shirazi is an expert in the regulatory requirements for medicines, clinical trials, product formulation and quality control.
Dr. Weisstuch is the Associate Director of Child and Adult Psychiatry at the Mount Sinai Medical Center in New York. He has won the following awards: selected as a Super Psychiatrist in Monsey, NY by the International Association of Healthcare Professionals (IAHCP), an award for education of medical specialty at Mount Sinai school, and teacher of the year for educating students of the same school. In addition, was appointed physician of the year by the nursing staff of the Department of Psychiatry.
Dr. Cherkez has been an active member of the pharmacy and chemistry industry for over 45 years. His professional career is split into almost exact halves. The first half in the company Teva and the second with Agis (Perrigo Israel). Was Head of Chemical Research at Teva, and in 1985 joined Agis (now known as Perrigo) as the founder and president of ChemAgis group.